Lower hemoglobin-to-red cell distribution width ratio in patients with imaging-confirmed peripheral artery disease: a retrospective case-control study

Background Peripheral artery disease (PAD) encompasses clinically heterogeneous phenotypes ranging from asymptomatic disease to chronic limb-threatening ischemia. The hemoglobin-to-red cell distribution width ratio (Hb/RDW), calculated from hemoglobin (Hb) and red cell distribution width (RDW), may reflect complementary erythrocyte-related processes; however, its relationship with clinically confirmed PAD remains incompletely defined. Objective To compare the Hb/RDW ratio between patients with imaging-confirmed PAD and control participants without documented PAD and to explore its ability to distinguish the two groups within a selected retrospective case-control sample. Methods This retrospective case-control study included 50 patients with imaging-confirmed PAD and 50 age- and sex-matched controls without documented PAD or major cardiovascular disease. Hemoglobin, RDW, lipid parameters, and other laboratory variables were obtained from medical records. The Hb/RDW ratio was calculated by dividing Hb (g/dL) by RDW (%). Symptom severity and standardized Fontaine or Rutherford classifications were not consistently available; therefore, stage-specific analyses were not performed. Exploratory receiver operating characteristic analysis was used to assess within-sample discrimination. Results Patients with PAD had a higher RDW than controls (14.8 ± 2.0% vs. 13.4 ± 1.3%; p = 0.01) and a lower Hb/RDW ratio (0.95 ± 0.16 vs. 1.06 ± 0.15; p < 0.01). Hemoglobin levels did not differ significantly between the groups. The Hb/RDW ratio demonstrated moderate discrimination between PAD cases and controls, with an area under the curve of 0.72 (95% CI, 0.63–0.81; p < 0.001). Conclusion The Hb/RDW ratio was lower in patients with imaging-confirmed PAD, predominantly because of higher RDW, and showed moderate discrimination within this selected study population. Because clinical stage was not consistently available and the ROC findings were not externally validated, these results should be regarded as hypothesis-generating and do not establish screening, diagnostic, or prognostic utility. Prospective stage-specific studies, particularly in asymptomatic or early PAD, are required.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-20
DOI
https://doi.org/10.3389/fcvm.2026.1963000
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lower hemoglobin-to-red cell distribution width ratio in patients with imaging-confirmed peripheral artery disease: a retrospective case-control study

Hüseyin Tezcan, Canan Aydoğan
2 links
Frontiers in Cardiovascular Medicine
Peripheral Artery Disease Management
article

Lower hemoglobin-to-red cell distribution width ratio in patients with imaging-confirmed peripheral artery disease: a retrospective case-control study

Hüseyin Tezcan, Canan Aydoğan
article en

Abstract

Background Peripheral artery disease (PAD) encompasses clinically heterogeneous phenotypes ranging from asymptomatic disease to chronic limb-threatening ischemia. The hemoglobin-to-red cell distribution width ratio (Hb/RDW), calculated from hemoglobin (Hb) and red cell distribution width (RDW), may reflect complementary erythrocyte-related processes; however, its relationship with clinically confirmed PAD remains incompletely defined. Objective To compare the Hb/RDW ratio between patients with imaging-confirmed PAD and control participants without documented PAD and to explore its ability to distinguish the two groups within a selected retrospective case-control sample. Methods This retrospective case-control study included 50 patients with imaging-confirmed PAD and 50 age- and sex-matched controls without documented PAD or major cardiovascular disease. Hemoglobin, RDW, lipid parameters, and other laboratory variables were obtained from medical records. The Hb/RDW ratio was calculated by dividing Hb (g/dL) by RDW (%). Symptom severity and standardized Fontaine or Rutherford classifications were not consistently available; therefore, stage-specific analyses were not performed. Exploratory receiver operating characteristic analysis was used to assess within-sample discrimination. Results Patients with PAD had a higher RDW than controls (14.8 ± 2.0% vs. 13.4 ± 1.3%; p = 0.01) and a lower Hb/RDW ratio (0.95 ± 0.16 vs. 1.06 ± 0.15; p < 0.01). Hemoglobin levels did not differ significantly between the groups. The Hb/RDW ratio demonstrated moderate discrimination between PAD cases and controls, with an area under the curve of 0.72 (95% CI, 0.63–0.81; p < 0.001). Conclusion The Hb/RDW ratio was lower in patients with imaging-confirmed PAD, predominantly because of higher RDW, and showed moderate discrimination within this selected study population. Because clinical stage was not consistently available and the ROC findings were not externally validated, these results should be regarded as hypothesis-generating and do not establish screening, diagnostic, or prognostic utility. Prospective stage-specific studies, particularly in asymptomatic or early PAD, are required.

Frontiers in Cardiovascular MedicineVol. 13
Selçuk University (TR), Konya Numune Hastanesi (TR)
Good health and well-being
Peripheral Artery Disease Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon